To view the PDF file, sign up for a MySharenet subscription.

MEDICLINIC INTERNATIONAL PLC - Board committee changes

Release Date: 20/03/2017 14:30
Code(s): MEI     PDF:  
Wrap Text
Board committee changes

Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
(“Mediclinic” or “the Company”)

20 March 2017

BOARD COMMITTEE CHANGES

The Company announces that, following a review of the composition of the Board Committees, the
membership of the Committees will be as follows, with effect from 17 March 2017.

- The Audit and Risk Committee will continue to be chaired by Desmond Smith and its other
  members will comprise Alan Grieve, Seamus Keating and Trevor Petersen.

- The Remuneration Committee will continue to be chaired by Trevor Petersen and its other
  members will comprise Prof Dr Robert Leu and Seamus Keating.

- The Nomination Committee will be chaired by Dr Edwin Hertzog and its other members will
  comprise Jannie Durand (with Pieter Uys as his alternate), Prof Dr Robert Leu, Trevor Petersen
  and Desmond Smith.

- The Clinical Performance and Sustainability Committee will continue to be chaired by Dr Edwin
  Hertzog and its members will comprise Nandi Mandela, Danie Meintjes and Prof Dr Robert Leu.

- The Investment Committee will continue to be chaired by Dr Edwin Hertzog and its other
  members will comprise Jannie Durand (with Pieter Uys as his alternate), Alan Grieve, Seamus
  Keating, Danie Meintjes and Jurgens Myburgh.

Mediclinic’s primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South
Africa and on the NSX in Namibia.

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information please contact:

Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com

Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600

Date: 20/03/2017 02:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story